vs
Crinetics Pharmaceuticals, Inc.（CRNX）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Rocky Mountain Chocolate Factory, Inc.的季度营收约是Crinetics Pharmaceuticals, Inc.的1.2倍（$7.5M vs $6.2M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -1993.4%，领先1991.4%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-93.4M）
Crinetics Pharmaceuticals是一家全球化制药企业，由Scott Struthers、Frank Zhu、Ana Kusnetzow、Stephen F. Betz于2008年共同创立，总部位于美国加利福尼亚州圣迭戈，专注于内分泌相关疾病的治疗药物研发，2018年在纳斯达克正式上市。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
CRNX vs RMCF — 直观对比
营收规模更大
RMCF
是对方的1.2倍
$6.2M
净利率更高
RMCF
高出1991.4%
-1993.4%
自由现金流更多
RMCF
多$92.1M
$-93.4M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $7.5M |
| 净利润 | $-122.8M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -2169.6% | 1.1% |
| 净利率 | -1993.4% | -2.1% |
| 营收同比 | — | -4.4% |
| 净利润同比 | -52.4% | 81.7% |
| 每股收益（稀释后） | $-1.30 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRNXRMCF
| Q4 25 | $6.2M | $7.5M | ||
| Q3 25 | — | $6.8M | ||
| Q2 25 | $1.0M | $6.4M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | $0 | $7.9M | ||
| Q3 24 | $0 | $6.4M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $7.3M |
净利润CRNXRMCF
| Q4 25 | $-122.8M | $-155.0K | ||
| Q3 25 | — | $-662.0K | ||
| Q2 25 | $-115.6M | $-324.0K | ||
| Q1 25 | — | $-2.9M | ||
| Q4 24 | $-80.6M | $-847.0K | ||
| Q3 24 | $-76.8M | $-722.0K | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $-1.6M |
毛利率CRNXRMCF
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
营业利润率CRNXRMCF
| Q4 25 | -2169.6% | 1.1% | ||
| Q3 25 | — | -7.0% | ||
| Q2 25 | -12523.0% | -2.3% | ||
| Q1 25 | — | -30.3% | ||
| Q4 24 | — | -8.9% | ||
| Q3 24 | — | -14.3% | ||
| Q2 24 | — | -25.4% | ||
| Q1 24 | — | -21.7% |
净利率CRNXRMCF
| Q4 25 | -1993.4% | -2.1% | ||
| Q3 25 | — | -9.7% | ||
| Q2 25 | -11216.0% | -5.1% | ||
| Q1 25 | — | -32.5% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -25.9% | ||
| Q1 24 | — | -21.9% |
每股收益（稀释后）CRNXRMCF
| Q4 25 | $-1.30 | $-0.02 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $-1.23 | $-0.04 | ||
| Q1 25 | — | $-0.38 | ||
| Q4 24 | $-0.86 | $-0.11 | ||
| Q3 24 | $-0.96 | $-0.11 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $992.1M | $6.0M |
| 总资产 | $1.1B | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRNXRMCF
| Q4 25 | $1.0B | $641.0K | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | $1.2B | $893.0K | ||
| Q1 25 | — | $720.0K | ||
| Q4 24 | $1.4B | $1.1M | ||
| Q3 24 | $862.7M | $973.0K | ||
| Q2 24 | — | $637.0K | ||
| Q1 24 | — | $2.1M |
股东权益CRNXRMCF
| Q4 25 | $992.1M | $6.0M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | $1.2B | $6.7M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | $1.3B | $9.8M | ||
| Q3 24 | $833.0M | $10.5M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | $10.6M |
总资产CRNXRMCF
| Q4 25 | $1.1B | $20.7M | ||
| Q3 25 | — | $22.3M | ||
| Q2 25 | $1.3B | $20.1M | ||
| Q1 25 | — | $21.2M | ||
| Q4 24 | $1.4B | $21.6M | ||
| Q3 24 | $937.4M | $21.1M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-92.9M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-93.4M | $-1.3M |
| 自由现金流率自由现金流/营收 | -1515.3% | -16.9% |
| 资本支出强度资本支出/营收 | 7.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-311.5M | — |
8季度趋势，按日历期对齐
经营现金流CRNXRMCF
| Q4 25 | $-92.9M | $-1.2M | ||
| Q3 25 | — | $-488.0K | ||
| Q2 25 | $-85.9M | $350.0K | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $-64.7M | $-2.1M | ||
| Q3 24 | $-62.8M | $-3.5M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | — | $129.0K |
自由现金流CRNXRMCF
| Q4 25 | $-93.4M | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | $-89.1M | $182.0K | ||
| Q1 25 | — | — | ||
| Q4 24 | $-65.7M | — | ||
| Q3 24 | $-63.4M | $-4.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-352.3K |
自由现金流率CRNXRMCF
| Q4 25 | -1515.3% | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | -8637.5% | 2.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -72.6% | ||
| Q2 24 | — | -40.2% | ||
| Q1 24 | — | -4.9% |
资本支出强度CRNXRMCF
| Q4 25 | 7.4% | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | 310.6% | 2.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRNX
| Products | $5.4M | 88% |
| Other | $741.0K | 12% |
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
